genetic barrier - clinical cases | roger paredes, md, phd
Published 4 years ago • 74 plays • Length 22:54Download video MP4
Download video MP3
Similar videos
-
27:24
resistance to integrase inhibitors | what clinicians need to know | roger paredes, md, phd
-
28:58
switching arv therapy - clinical and resistance considerations - roger paredes, md, phd
-
17:35
case discussion: co-morbidities in people living with hiv | roger paredes, md, phd
-
26:22
two versus three drugs - what are the data? - roger paredes, md, phd
-
0:39
invitation by roger paredes, md, phd | european meeting on hiv & hepatitis 2021
-
17:15
roger paredes | understanding and managing multi-class resistance
-
21:37
rio hiv clinical forum 2020 | roger paredes - instis resistance and relevance for clinical use
-
26:49
long-term evolution of long covid - roger paredes, md, phd
-
8:37
5 happiest types of doctors by specialty
-
7:01
are you destined to go bald? baldness genes revealed
-
1:17:03
case based approach to concepts in genetics
-
12:14
long covid pathogenesis - what have we learned so far - roger paredes, md, phd
-
1:30:03
session 2: reduced drug regimens: scientific considerations | full livestream
-
20:55
optimizing clinical utility of integrase inhibitors | anton pozniak, md, frcp
-
1:13
clinical genetics
-
29:24
the integrase inhibitors drug class: a comparative clinical review | ian frank
-
1:15:47
session 1: transmission
-
23:44
attributes of instis as a first line treatment option - sanjay bhagani, bsc, frcp
-
1:20
genetic testing for health care professionals
-
29:46
resistance to integrase inhibitors | charles boucher, md, phd
-
1:19:51
session 3: resistance to long-acting antivirals | full livestream